Finanzwire Finanzwire
Basculer en Français
11318 Companies
251478 Keywords
180598 Articles
137303 Press releases
Headlines Articles Press releases Zuellig Pharma Remove
  1. Home
  2. Companies
  3. Zuellig Pharma
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 02:50, 11 months 10 days ago

    Zuellig Pharma Launches Cutting-Edge Clinical Trial Support Center in South Korea

    Automation Clinical Trials South Korea Healthcare Logistics Zuellig Pharma
  • PRESS RELEASE

    published on 12/01/2025 at 02:45, 11 months 10 days ago

    Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needs

    Zuellig Pharma opens a state-of-the-art Clinical Trial Support Innovation Center in South Korea, enhancing clinical logistics with automation and stringent compliance standards
    Logistics Automation Healthcare Clinical Trials Zuellig Pharma
    Logo of Zuellig Pharma
  • PRESS RELEASE

    published on 08/01/2023 at 10:00, 3 years 3 months ago

    Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

    Logo of Zuellig Pharma
Accesswire
  • Published on 11/11/2026 at 10:30, 20 minutes ago

    Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services

  • Published on 11/11/2026 at 03:30, 7 hours 20 minutes ago

    CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary

  • Published on 11/11/2026 at 00:40, 10 hours 10 minutes ago

    Upgraded Tunkillia MRE Validates Optimised Scoping Study

  • Published on 11/10/2026 at 23:30, 11 hours 20 minutes ago

    CCL Industries Announces 2026 Third Quarter Results

  • Published on 11/10/2026 at 23:00, 11 hours 50 minutes ago

    Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary

View all ACCESSWIRE
EQS Group
  • Published on 11/11/2026 at 10:10, 40 minutes ago

    EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year

  • Published on 11/11/2026 at 10:00, 50 minutes ago

    GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026

  • Published on 11/11/2026 at 09:40, 1 hour 9 minutes ago

    Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report

  • Published on 11/11/2026 at 09:25, 1 hour 24 minutes ago

    DOBOT Unveils Three New Products at Its 2026 Robotics Ecosystem Conference

  • Published on 11/11/2026 at 09:05, 1 hour 44 minutes ago

    DeepL unveils Aure, its most lifelike Voice AI translation model yet

View all EQS
Les Echos
  • Published on 11/10/2026 at 17:31, 17 hours 18 minutes ago

    CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.

  • Published on 11/10/2026 at 14:00, 20 hours 49 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026

  • Published on 11/10/2026 at 11:02, 23 hours 47 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026

  • Published on 11/10/2026 at 07:00, 1 day 3 hours ago

    bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance

  • Published on 11/09/2026 at 18:30, 1 day 16 hours ago

    Air Liquide has successfully issued a CHF 390 million multi-tranche bond

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy